
--- Page 1 ---
Page 1 of 2 UUID:B3CFFF02-89AA-43AE-B19B-BEE6817AA997 Patient: TCGA-B6-A3ZX-01A-PR Redacted AP Surgical Pathology: Additional infod Surg Path CLINICAL HISTORY: Rule out malignancy of left breast. Palpable left breast mass within large axillary node.  If invasive carcinoma, please obtain ER, PR, EGFR, HER2/Neu by immunohistochemistry; for all 2+ IHc results please do FIsh analysis. GROSS EXAMINATION: A. "usncb left breast, number of cores 4, 11:00 site 1", received in formalin is a 1 x 0.6 x 0.2 cm aggregate of yellow-tan fibrofatty tissue which is submitted entirely in a mesh bag in block Al. B. "usncb left breast, number of cores 4, axilla site 2", received in formalin is a 0.9 x 0.6 x 0.2 cm aggregate of yellow-tan fibrofatty tissue which is submitted entirely in a mesh bag in block B1.. 1cD-O-3 axnXarci^oma,i^F1Hra Hi nq MICROSCOPIC EXAMINATION:S ducfJ 0ncl 1Obwar f5zz 13 Microscopic examination is performed.. 5i$:br<gst,^XS C5:9 7-ZaZ DIAGNOSIS : A. "LEFT BREAST, 11:OO, SITE ONE" (ULTRASOUND GUIDED NEEDLE CORE BIOPSY):S INVASIVE ADENOCARCINOMA OF THE BREAST.S HISTOLOGIC TYPE: DUCTAL, WITH LOBULAR FEATURES. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 2. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: SOLID. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. ESTROGEN/PROGESTERONE RECEPTOR, HER2/NEU, AND EGFR ANALYSIS: PENDING.S PARAFFIN BLOCK NUMBER: A1. RESULTS WILL BE ISSUED IN A SEPARATE REPORT FROM THE IMAGE CYTOMETRYS LAB. B. "LEFT BREAST, AXILLA, SITE TWO" (ULTRASOUND GUIDED NEEDLE CORE BIOPSY) : LYMPH NODE WITH METASTATIC DUCTAL ADENOCARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above specimen(s) and have rendered the above diagnosis(es). Electronically signed:  ~: ADDENDUM 1: Please see for results of supplementary tests. I certify that I personally conducted the diagnostic evaluation of the above specimen(s) and have rendered the above diagnosis(es).